Skip to content
Clinical Trials – home
Graegis Pharmaceuticals Limited
Sponsor

Graegis Pharmaceuticals Limited

United Kingdom The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, CB22 3FH, United Kingdom

About the sponsor

Clinical research in radiodermatitis centers on skin reactions associated with radiotherapy, with attention to prevention of treatment-related cutaneous injury in patients receiving breast cancer radiation care.

  • Radiotherapy-associated skin toxicity
  • Radiation dermatitis prevention
  • Cutaneous adverse effects

The sponsor’s activity in this area is linked to supportive care for individuals undergoing adjuvant breast irradiation, with interest in protecting skin integrity during cancer treatment.

About Specializations

Graegis Pharmaceuticals Limited runs clinical trials in conditions such as Radiation skin injury, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Radiation skin injury

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amifostine Thiol
  • Sponsor:Graegis Pharmaceuticals Limited

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.